Related Experiment Video
Updated: May 7, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Nuclear receptors - target molecules for isoflavones in cancer chemoprevention
Lucia Bialešová1, Július Brtko, Vladimír Lenko
1Laboratory of Molecular Endocrinology, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic. ueenmace@savba.sk.
Abstract:
Breast cancer is the most occurring type of cancer among women. In Slovakia, there are yearly diagnosed about 1900 new cases of this disease. Breast cancer treatment is very expensive, psychic stressful and in some cases ineffective. Therefore, it is essential to search for new and/or alternative methods for breast cancer treatment, since nuclear receptors are considered to be a central goal for maximizing treatment opportunities in breast cancer. Among natural ligands for estrogen receptors (ERα and ERβ), which are member of nuclear receptors superfamily, belongs also isoflavones. These natural compounds have similar structure to main female hormon-17β estradiol. A rich source of isoflavones is soy and its products. Three aglycones form of isoflavones (genistein, daidzein, glycitein) are predominantly found in soybean and red clover. Among other important isoflavones belongs also biochanin A and formononetin.
Insights
This study explores isoflavones, natural compounds found in soy, as potential treatments for breast cancer. Research into these estrogen receptor ligands offers new avenues for breast cancer therapy.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Breast cancer is a leading cancer in women, with high treatment costs and variable effectiveness.
- Nuclear receptors are key targets for improving breast cancer treatment strategies.
- Isoflavones, natural compounds structurally similar to 17β-estradiol, are ligands for estrogen receptors (ERα and ERβ).
Purpose of the Study:
- To investigate the potential of isoflavones as alternative or supplementary treatments for breast cancer.
- To highlight the role of nuclear receptors, specifically estrogen receptors, in breast cancer therapy.
- To identify natural sources and key types of isoflavones relevant to breast cancer research.
Main Methods:
- Literature review on isoflavones and their interaction with estrogen receptors.
- Analysis of isoflavone structures and their similarity to 17β-estradiol.
- Identification of natural sources rich in isoflavones, such as soy and red clover.
Main Results:
- Isoflavones, including genistein, daidzein, glycitein, biochanin A, and formononetin, are found in soy and red clover.
- These compounds act as natural ligands for estrogen receptors (ERα and ERβ).
- Their structural similarity to 17β-estradiol suggests potential endocrine activity relevant to breast cancer.
Conclusions:
- Isoflavones represent a promising area for developing novel breast cancer treatments.
- Targeting nuclear receptors with natural ligands like isoflavones could enhance therapeutic opportunities.
- Further research into isoflavones may lead to more effective and less burdensome breast cancer therapies.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Signal Transduction: Overview
Typically, signal transduction involves three...

